BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36768686)

  • 1. Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review.
    Lominadze Z; Hill K; Shaik MR; Canakis JP; Bourmaf M; Adams-Mardi C; Abutaleb A; Mishra L; Shetty K
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma.
    Koh B; Tan DJH; Lim WH; Wong JSL; Ng CH; Chan KE; Wang M; Yong WP; Dan YY; Wang LZ; Tan N; Muthiah M; Kow A; Syn NL; Huang DQ; Yau T
    Oncoimmunology; 2023; 12(1):2214478. PubMed ID: 37284696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma from the view of a transplant surgeon.
    Matěj K; Pavel T; Jiří F
    Klin Onkol; 2020; 33(Supplementum 3):13-19. PubMed ID: 33213160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review.
    Qiu J; Tang W; Du C
    Curr Cancer Drug Targets; 2020; 20(9):720-727. PubMed ID: 32433005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.
    Wang ZY; Geng L; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):145-9. PubMed ID: 25865686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo hepatocellular carcinoma of liver allograft: a neglected issue.
    Trevisani F; Garuti F; Cucchetti A; Lenzi B; Bernardi M
    Cancer Lett; 2015 Feb; 357(1):47-54. PubMed ID: 25444925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy.
    Tabrizian P; Zeitlhoefler M; Hassan AT; Marino R
    Curr Opin Organ Transplant; 2024 Apr; 29(2):144-154. PubMed ID: 38164882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of immuno-oncologic therapy in hepatocellular carcinoma in the context of liver transplantation. An interdisciplinary benefit/risk assessment].
    Vogel A; Sterneck M; Vondran F; Waidmann O; Klein I; Lindig U; Nadalin S; Settmacher U; Tacke F; Schlitt HJ; Wege H
    Z Gastroenterol; 2022 Feb; 60(2):184-191. PubMed ID: 34670296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LI-RADS and transplantation for hepatocellular carcinoma.
    Tang A; Fowler KJ; Chernyak V; Chapman WC; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):193-202. PubMed ID: 28612162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?
    Roth GS; Villeret F; Decaens T; Merle P; Nahon P
    Liver Int; 2023 Mar; 43(3):546-557. PubMed ID: 36571256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Williams B; Fisher RA
    Mol Med; 2006; 12(4-6):97-104. PubMed ID: 16953559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation.
    Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S
    Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation.
    Stippel DL; Kasper HU; Schleimer K; Benz C; Hölscher AH; Beckurts KT
    Transplant Proc; 2003 Jun; 35(4):1423-4. PubMed ID: 12826177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review.
    Qiao ZY; Zhang ZJ; Lv ZC; Tong H; Xi ZF; Wu HX; Chen XS; Xia L; Feng H; Zhang JJ; Xia Q
    Front Immunol; 2021; 12():653437. PubMed ID: 34349755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria.
    Ravaioli M; Grazi GL; Piscaglia F; Trevisani F; Cescon M; Ercolani G; Vivarelli M; Golfieri R; D'Errico Grigioni A; Panzini I; Morelli C; Bernardi M; Bolondi L; Pinna AD
    Am J Transplant; 2008 Dec; 8(12):2547-57. PubMed ID: 19032223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma.
    Woo SM; Kimchy AV; Sequeira LM; Dorris CS; He AR; Rangnekar AS
    Curr Oncol; 2022 Dec; 29(12):9813-9825. PubMed ID: 36547185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.